Olema Pharmaceuticals Stock Market Value
| OLMA Stock | USD 10.12 0.40 4.12% |
| Symbol | Olema |
Olema Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Olema Pharmaceuticals. If investors know Olema will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Olema Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.28) | Return On Assets (0.32) | Return On Equity (0.52) |
The market value of Olema Pharmaceuticals is measured differently than its book value, which is the value of Olema that is recorded on the company's balance sheet. Investors also form their own opinion of Olema Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Olema Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Olema Pharmaceuticals' market value can be influenced by many factors that don't directly affect Olema Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Olema Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Olema Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Olema Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Olema Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Olema Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Olema Pharmaceuticals.
| 05/09/2023 |
| 11/29/2024 |
If you would invest 0.00 in Olema Pharmaceuticals on May 9, 2023 and sell it all today you would earn a total of 0.00 from holding Olema Pharmaceuticals or generate 0.0% return on investment in Olema Pharmaceuticals over 570 days. Olema Pharmaceuticals is related to or competes with Sana Biotechnology, Cullinan Oncology, Zentalis Pharmaceuticals, Molecular Partners, Mineralys Therapeutics,, AN2 Therapeutics, and Pharvaris. Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and comm... More
Olema Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Olema Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Olema Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 19.19 | |||
| Value At Risk | (5.89) | |||
| Potential Upside | 6.17 |
Olema Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Olema Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Olema Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Olema Pharmaceuticals historical prices to predict the future Olema Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.41) | |||
| Total Risk Alpha | (0.76) | |||
| Treynor Ratio | (0.06) |
Olema Pharmaceuticals Backtested Returns
Olema Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0241, which implies the firm had a -0.0241% return per unit of risk over the last 3 months. Olema Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Olema Pharmaceuticals' Variance of 16.37, coefficient of variation of (2,977), and Risk Adjusted Performance of (0.02) to confirm the risk estimate we provide. The company holds a Beta of 2.29, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Olema Pharmaceuticals will likely underperform. At this point, Olema Pharmaceuticals has a negative expected return of -0.0989%. Please make sure to check Olema Pharmaceuticals' kurtosis, market facilitation index, and the relationship between the value at risk and rate of daily change , to decide if Olema Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.09 |
Very weak reverse predictability
Olema Pharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between Olema Pharmaceuticals time series from 9th of May 2023 to 18th of February 2024 and 18th of February 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Olema Pharmaceuticals price movement. The serial correlation of -0.09 indicates that less than 9.0% of current Olema Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.09 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 2.53 |
Olema Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Olema Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Olema Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Olema Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Olema Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Olema Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Olema Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Olema Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Olema Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Olema Pharmaceuticals Lagged Returns
When evaluating Olema Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Olema Pharmaceuticals stock have on its future price. Olema Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Olema Pharmaceuticals autocorrelation shows the relationship between Olema Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Olema Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Olema Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Olema Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Olema Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Olema Pharmaceuticals Stock:Check out Olema Pharmaceuticals Correlation, Olema Pharmaceuticals Volatility and Olema Pharmaceuticals Alpha and Beta module to complement your research on Olema Pharmaceuticals. For information on how to trade Olema Stock refer to our How to Trade Olema Stock guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Olema Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.